AssayIndex

HJ-2507-F5796

Selank · 20 mg declared · Hubei Jianxiang Bioscience Co., Ltd. · manufactured 24 Jul 2025

CHARACTERISED
Lot code
HJ-2507-F5796
Supplier
HJ — Hubei Jianxiang Bioscience Co., Ltd.
Compound
Selank
Compound class
Neuroactive and cognitive peptides
Declared label claim
20mg
Manufacture date
24 Jul 2025
Index quarter
2025-Q3
Independent assays
9
Laboratories involved
Janoshik, PeptideMeter, Kestrel, VendorInvestigate
Provenance mix
Buyer-sourced ×9
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 9
Median purity 99.71% n=9
Spread (max − min) 0.55pp n=9
Standard deviation 0.222pp n=9
97.597.998.398.899.299.7100.1This lot (HJ-2507-F5796)This lot (HJ-2507-F5796): Q1 99.31, median 99.71, Q3 99.73, n=9n=9All SelankAll Selank: Q1 99.16, median 99.55, Q3 99.79, n=139outlier 97.64outlier 97.92outlier 98.06outlier 98.08n=139 Purity (% area)
Figure 1. This lot's independent purity results against the whole Selank record set in the index. The vertical line is the index acceptance specification for the neuroactive and cognitive peptides class, 99.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 9

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019909HJ-2507-F5796Janoshik2025-Q399.718.97100.3Buyer-sourced1MARGINAL
AX-2025-019910HJ-2507-F5796Janoshik2025-Q399.738.34Buyer-sourced1MARGINAL
AX-2025-019911HJ-2507-F5796Janoshik2025-Q399.718.24Buyer-sourced2FAIL
AX-2025-019912HJ-2507-F5796PeptideMeter2025-Q399.758.3691.1Buyer-sourced1MARGINAL
AX-2025-019913HJ-2507-F5796Kestrel2025-Q399.838.0891.1Buyer-sourced1MARGINAL
AX-2025-019914HJ-2507-F5796PeptideMeter2025-Q399.288.3497.2Buyer-sourced1MARGINAL
AX-2025-019915HJ-2507-F5796Janoshik2025-Q399.508.21Buyer-sourced1MARGINAL
AX-2025-019916HJ-2507-F5796VendorInvestigate2025-Q399.308.79Buyer-sourced1MARGINAL
AX-2025-019917HJ-2507-F5796Janoshik2025-Q399.318.23Buyer-sourced1MARGINAL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Janoshik599.71, 99.73, 99.71, 99.50, 99.3199.7130min+0.0099.71
PeptideMeter299.75, 99.2899.5228min-0.0599.56
Kestrel199.8399.8315min+0.2499.59
VendorInvestigate199.3099.3032min-0.1199.41

This lot contributes 6 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)99.599.71divergence -0.21 pp vs batch median
Total impurities (% area)not stated0.29
Largest single impurity (% area)not stated0.13
Water (%)7.28.97
Counter-ion (%)6.77.61
Peptide content (%w/w)85.582.96
Endotoxin (EU/mg)0.38not determined
Method stated on certificateNOno method section — the result cannot be reconciled against any other
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
tuftsin fragment (−417 Da)9 / 90.150.11–0.40
des-Thr (−101 Da)9 / 90.060.02–0.19
acetyl adduct (+42 Da)9 / 90.040.02–0.09
diketopiperazine (−18 Da)8 / 90.080.04–0.21
Section 7

What this rollup does not establish